Lōkahi Therapeutics, GlucoTrack unit, sets Oct. 14 launch for Qare GLP-1 comparative health platform

GCTK•2026-09-30

Lōkahi Therapeutics introduced Qare, a real-time comparative health platform focused on GLP-1 medications, with public availability scheduled for Oct. 14, 2026. The company expects to expand the platform into additional therapeutic categories in later releases.

Lōkahi Therapeutics, GlucoTrack unit, sets Oct. 14 launch for Qare GLP-1 comparative health platform

1. Qare launch scheduled

Related News

Reliance Global amends 8-K to correct transaction closing date to Sept. 24, 2026

US goods trade deficit widens sharply in August

Lee Enterprises appoints Gregory Hoffmann to board, names him to governance committee

Nasdaq trade halt continues; reason unavailable at 9:40 a.m.

Homestolife management says H1 2026 revenue rises 9.7% on stronger export demand